← Browse by Condition
Medical Condition
steroid sensitive nephrotic syndrome
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT05786768 Phase 2, Phase 3
Recruiting
Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome
Enrollment
88 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT06065852
Recruiting
National Registry of Rare Kidney Diseases
Enrollment
35,000 pts
Location
United Kingdom
Sponsor
UK Kidney Association